Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Jefferies Downgrades Paratek Pharmaceuticals to Hold, Lowers Price Target to $2.15

Author: Benzinga Newsdesk | June 07, 2023 05:19am
Jefferies analyst Suji Jeong downgrades Paratek Pharmaceuticals (NASDAQ:PRTK) from Buy to Hold and lowers the price target from $5 to $2.15.

Posted In: PRTK